Supernus Pharmaceuticals Inc (SUPN)

Income Tax Expense

-$13.58M

TTM · Period ending: · USD

SUPN logo

SUPN Income Tax Expense

Latest reported-$13.58M
SUPN TTM Income Tax (-$105.32M → -$13.58M)
High-resolution chart · PNG

SUPN income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Supernus Pharmaceuticals Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
-13,580,000
-20,133,000
-10,480,000
-1,617,000
17,666,000
29,882,000
24,005,000
12,766,000
32,185,000
9,503,000
1,453,000
11,297,000
-16,761,000
2,994,000
32,000
-10,018,000
-427,000
3,623,000
19,751,000
29,067,000
34,383,000
39,417,000
41,698,000
40,556,000
38,572,000
36,048,000
34,431,000
39,522,000
37,152,000
30,252,000
29,183,000
37,712,000
36,301,000
42,239,000
43,335,000
23,164,000
-26,475,000
-34,818,000
-40,546,000
-41,604,000
1,144,000
1,092,000
956,000
1,744,000
2,977,000
2,315,000
2,253,000
1,291,000
0
0
0
1,143,000
1,143,000
1,686,000
1,686,000
-103,576,000
-103,757,000
-105,319,000
-105,319,000
-11,553,113
-11,372,113
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.